H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 17.24 HKD 0.7% Market Closed
Market Cap: 102.3B HKD
Have any thoughts about
Hansoh Pharmaceutical Group Company Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Hansoh Pharmaceutical Group Company Ltd

Current Assets 27.4B
Cash & Short-Term Investments 23.5B
Receivables 2.9B
Other Current Assets 970.4m
Non-Current Assets 4.3B
Long-Term Investments 743.4m
PP&E 3.3B
Intangibles 196.6m
Current Liabilities 3.4B
Accounts Payable 174.6m
Other Current Liabilities 3.3B
Non-Current Liabilities 336.6m
Long-Term Debt 64.1m
Other Non-Current Liabilities 272.5m

Balance Sheet
Hansoh Pharmaceutical Group Company Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
197
257
653
8 238
4 285
14 702
17 615
22 435
Cash
0
0
0
0
4 285
14 702
17 615
22 435
Cash Equivalents
197
257
653
8 238
0
0
0
0
Short-Term Investments
1 147
1 467
2 840
6 355
9 433
4 231
4 008
2 422
Total Receivables
1 740
2 213
2 674
2 279
3 210
3 782
3 674
3 321
Accounts Receivables
1 572
1 372
1 605
1 551
2 744
3 247
3 534
3 210
Other Receivables
167
842
1 069
728
467
535
140
111
Inventory
353
439
480
414
299
410
448
576
Other Current Assets
27
42
38
161
59
54
86
130
Total Current Assets
3 464
4 418
6 684
17 448
17 286
23 179
25 832
28 883
PP&E Net
1 231
1 329
1 581
2 123
3 468
3 569
3 483
3 294
PP&E Gross
1 231
1 329
1 581
2 123
3 468
3 569
3 483
3 294
Accumulated Depreciation
536
655
773
925
1 128
1 360
1 645
1 963
Intangible Assets
6
9
10
5
10
17
33
177
Long-Term Investments
0
0
0
0
28
395
654
685
Other Long-Term Assets
120
118
139
0
0
0
0
0
Total Assets
4 821
N/A
5 874
+22%
8 414
+43%
19 575
+133%
20 792
+6%
27 160
+31%
30 002
+10%
33 039
+10%
Liabilities
Accounts Payable
45
99
159
193
124
248
222
164
Accrued Liabilities
752
849
1 028
1 459
1 877
2 201
1 925
1 969
Short-Term Debt
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
4
11
10
16
4 199
Other Current Liabilities
1 015
280
3 317
4 585
677
565
457
530
Total Current Liabilities
1 812
1 228
4 504
6 240
2 690
3 024
2 620
6 863
Long-Term Debt
0
0
0
6
82
3 818
4 362
104
Deferred Income Tax
35
128
243
285
122
267
351
255
Minority Interest
0
0
0
0
0
0
0
0
Other Liabilities
0
0
1 200
0
23
23
22
22
Total Liabilities
1 847
N/A
1 355
-27%
5 946
+339%
6 531
+10%
2 916
-55%
7 131
+145%
7 355
+3%
7 244
-2%
Equity
Common Stock
0
0
0
0
0
0
0
0
Retained Earnings
1 597
3 192
1 095
1 952
4 589
6 987
9 034
11 671
Additional Paid In Capital
1 302
1 302
1 302
10 837
14 009
14 024
13 932
14 096
Treasury Stock
0
0
0
0
0
58
28
109
Other Equity
75
24
70
256
722
924
291
137
Total Equity
2 974
N/A
4 519
+52%
2 468
-45%
13 044
+429%
17 876
+37%
20 029
+12%
22 647
+13%
25 795
+14%
Total Liabilities & Equity
4 821
N/A
5 874
+22%
8 414
+43%
19 575
+133%
20 792
+6%
27 160
+31%
30 002
+10%
33 039
+10%
Shares Outstanding
Common Shares Outstanding
5 161
5 161
5 161
5 789
5 919
5 918
5 920
5 924

See Also

Discover More